Inpatient: Non-formulary

• • This medication may be used as a patient’s own medication when continuing established therapy while a patient is hospitalized. In cases where a patient is hospitalized for active ulcerative colitis or Crohn’s disease, initiation of upadacitinib in the inpatient setting may be considered on a case[1]by-case basis when a new start is requested; there is limited data on its use in the pediatric population for inflammatory bowel diseases. For this to be initiated inpatient, insurance approval ideally will take place first to ensure that the medication can be continued outpatient.

• Micromedex
• CareNotes
• UpToDate
• Facts & Comparisons
• MedLinePlus (Patient Information)